Compass Inc Class A COMP 深 滬
交易中 01-30 10:47:28 美东时间
12.275
-0.755
-5.79%
華盛通- 最 高12.91
- 今 開12.91
- 成交量 327.17万股
- 最 低 12.215
- 昨 收 13.03
- 總市值 68.49亿
- 52周最高 13.955
- 市盈率 靜 --
- 換手率 0.59%
- 52周最低 5.655
- 委 比 -7.88%
- 總股本 5.58亿
- 歷史最高 22.11
- 量 比 1.16
- 振 幅 5.33%
- 歷史最低 1.815
- 每 手 1
- 風險率 1.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Marcus & Millichap Brokers $5.65M Sale of Red Hook Industrial Property
Marcus & Millichap Brokers $5.65M Sale of Red Hook Industrial Property Marcus & Millichap announced the sale of an 11,850-square-foot industrial property located at 30 Richards St. in Brooklyn's Red Hook neighborhood for $5.65 million. The transaction set a record price of $565 per square foot for a
01-29 03:18
Altor Completes Sale-Leaseback Transaction Generating Approximately $11 Million in Proceeds
Compass Diversified subsidiary, Altor Solutions, completed a $11 million sale-leaseback transaction, using proceeds to reduce debt. Altor will continue operations at leased facilities. The transaction aligns with CODI's strategy to enhance balance sheet strength and create shareholder value. Elias Sabo highlighted disciplined asset management. Altor provides protective and cold-chain packaging solutions, while CODI manages diversified middle-mark...
01-28 21:10
Compass Group plc publishes Sustainability Report
Compass Group plc publishes Sustainability Report Compass Group plc published a sustainability report highlighting several initiatives and achievements, including the implementation of a Deforestation Policy, monitoring of over 22,000 suppliers, labour agencies, and distributors through a third-part
01-28 00:55
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
U.S. RESEARCH ROUNDUP- CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP- CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies o
01-26 15:22
Real estate stocks decline amid geopolitical developments, weak earnings
Real estate stocks were largely in red this week, with the sector kicking off the quarterly earnings season on a sour note and heightened geopolitical uncertainty leading to increased volatility. Geop...
01-25 01:00
BRIEF-FDA Approves Compassionate Use Of Urcosimod (0.05%) For The Treatment Of Neuropathic Corneal Pain
BRIEF-FDA Approves Compassionate Use Of Urcosimod (0.05%) For The Treatment Of Neuropathic Corneal Pain Jan 23 (Reuters) - OKYO Pharma Ltd OK11.MU : FDA APPROVES COMPASSIONATE USE OF URCOSIMOD (0.05%) FOR THE TREATMENT OF NEUROPATHIC CORNEAL PAIN OKYO PHARMA LTD - TO INITIATE 120-PATIENT STUDY OF UR
01-23 20:01
Compass Minerals International Inc. to Release First-Quarter Fiscal 2026 Results and Host Conference Call
Compass Minerals International Inc. to Release First-Quarter Fiscal 2026 Results and Host Conference Call Compass Minerals International Inc. will release its first-quarter fiscal 2026 results on Wednesday, February 4, 2026, after the markets close. President and CEO Edward C. Dowling Jr. and CFO Pe
01-23 13:51
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
<p>OKYO Pharma获得了FDA对urcosimod用于治疗一名神经性角膜痛患者的授权。这是首个针对NCP的IND，并获得了快速通道资格。公司计划启动一项120患者的2b/3期试验。NCP是一种严重眼部疼痛疾病，目前无FDA批准的治疗方法。Urcosimod通过抑制免疫炎症和神经信号有望缓解症状。OKYO致力于开发创新疗法以解决该领域的迫切需求。</p>
01-23 12:00
The Real Brokerage Expands Seattle Presence with McConnell Group Acquisition
The Real Brokerage Expands Seattle Presence with McConnell Group Acquisition The Real Brokerage Inc., a leading real estate technology platform, has expanded its presence in the greater Seattle area by welcoming Sean McConnell and the McConnell Group to its network. Formerly known as the NK Team and
01-21 20:30
